Circulation

Papers
(The H4-Index of Circulation is 120. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Heart Disease and Stroke Statistics—2021 Update3704
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association3165
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association1705
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association1193
Cardiovascular Disease in Chronic Kidney Disease892
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association875
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines807
Myocarditis With COVID-19 mRNA Vaccines651
Call to Action: Structural Racism as a Fundamental Driver of Health Disparities: A Presidential Advisory From the American Heart Association631
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidel588
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines559
Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association520
2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association499
Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association409
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clini369
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice 367
Single-Cell Genomics Reveals a Novel Cell State During Smooth Muscle Cell Phenotypic Switching and Potential Therapeutic Targets for Atherosclerosis in Mouse and Human356
Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association330
Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association328
Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque320
Psychological Health, Well-Being, and the Mind-Heart-Body Connection: A Scientific Statement From the American Heart Association314
Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation304
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure296
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Cli271
Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)269
Evidence-Based Assessment of Genes in Dilated Cardiomyopathy267
Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association256
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction248
Stem Cell Pluripotency Genes Klf4 and Oct4 Regulate Complex SMC Phenotypic Changes Critical in Late-Stage Atherosclerotic Lesion Pathogenesis246
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association242
Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device242
Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe239
Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19236
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status234
Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial230
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial226
Integrated Single-Cell Atlas of Endothelial Cells of the Human Lung225
Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children223
Fruit and Vegetable Intake and Mortality217
Colchicine in Patients With Acute Coronary Syndrome208
Microthrombi as a Major Cause of Cardiac Injury in COVID-19207
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population207
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction206
SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes198
Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction198
Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies197
Status of Cardiovascular Health in US Adults and Children Using the American Heart Association’s New “Life’s Essential 8” Metrics: Prevalence Estimates From the National Health and Nutrition Examinati196
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Pr191
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex187
Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis187
Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes187
Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial187
Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling/Autophagy Hypothesis185
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function185
Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarction183
Single-Cell RNA Sequencing Unveils Unique Transcriptomic Signatures of Organ-Specific Endothelial Cells177
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease176
Correction to: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guideline175
Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women174
Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association171
Lack of Evidence of Angiotensin-Converting Enzyme 2 Expression and Replicative Infection by SARS-CoV-2 in Human Endothelial Cells170
Myocarditis After BNT162b2 and mRNA-1273 Vaccination169
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines168
Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease168
Myocarditis Temporally Associated With COVID-19 Vaccination167
Deep Neural Networks Can Predict New-Onset Atrial Fibrillation From the 12-Lead ECG and Help Identify Those at Risk of Atrial Fibrillation–Related Stroke166
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy163
Blood Pressure Effects of Sodium Reduction163
Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure163
Diagnosis and Management of Myocarditis in Children163
How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction?162
Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales160
Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure159
Fate and State of Vascular Smooth Muscle Cells in Atherosclerosis159
Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations159
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity158
Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial157
HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research157
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Gui157
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guide155
Single-Cell RNA Sequencing Analysis Reveals a Crucial Role for CTHRC1 (Collagen Triple Helix Repeat Containing 1) Cardiac Fibroblasts After Myocardial Infarction152
Cell-Free DNA to Detect Heart Allograft Acute Rejection152
Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase147
Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction147
Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association145
ECG-Based Deep Learning and Clinical Risk Factors to Predict Atrial Fibrillation144
COVID-19 Myocardial Pathology Evaluation in Athletes With Cardiac Magnetic Resonance (COMPETE CMR)143
Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial142
Personal-Level Protective Actions Against Particulate Matter Air Pollution Exposure: A Scientific Statement From the American Heart Association142
Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure With Preserved Ejection Fraction141
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention140
PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36138
Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial138
Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications138
Prevalence, Characteristics, and Outcomes of COVID-19–Associated Acute Myocarditis137
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association137
Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure136
Therapeutic and Diagnostic Translation of Extracellular Vesicles in Cardiovascular Diseases136
Hyperglycemia Induces Trained Immunity in Macrophages and Their Precursors and Promotes Atherosclerosis136
Ten-Year Differences in Women’s Awareness Related to Coronary Heart Disease: Results of the 2019 American Heart Association National Survey: A Special Report From the American Heart Association135
Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial135
Assessing and Addressing Cardiovascular Health in People Who Are Transgender and Gender Diverse: A Scientific Statement From the American Heart Association134
Sex Differences in Blood Pressure Associations With Cardiovascular Outcomes134
Assessing and Addressing Cardiovascular Health in LGBTQ Adults: A Scientific Statement From the American Heart Association134
Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin132
Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination132
Endotoxinemia Accelerates Atherosclerosis Through Electrostatic Charge–Mediated Monocyte Adhesion132
Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure])131
Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials130
A Unique Population of Regulatory T Cells in Heart Potentiates Cardiac Protection From Myocardial Infarction130
Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex130
Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 Countries130
COVID-19–Associated Nonocclusive Fibrin Microthrombi in the Heart129
Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association129
Circular RNA CircMAP3K5 Acts as a MicroRNA-22-3p Sponge to Promote Resolution of Intimal Hyperplasia Via TET2-Mediated Smooth Muscle Cell Differentiation128
Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy128
Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study126
Mavacamten Favorably Impacts Cardiac Structure in Obstructive Hypertrophic Cardiomyopathy125
Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial123
GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes123
Diagnosis and Management of Patients With Myocardial Injury After Noncardiac Surgery: A Scientific Statement From the American Heart Association120
Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation120
0.046556949615479